Literature DB >> 2870481

The two-syndrome concept and neuroendocrinology of schizophrenia.

T J Crow, I N Ferrier, E C Johnstone.   

Abstract

Schizophrenia sometimes remits and sometimes responds to neuroleptic drugs but is a disease that also has a poor long-term outcome, sometimes including behavioral deterioration and intellectual decline. It is proposed that there are two components to pathology: a neurochemical component, perhaps associated with a change in D-2 DA receptors, which is potentially reversible and neuroleptic-responsive and a structural and probably irreversible component, which includes changes in structures bordering the temporal horn of the lateral ventricle and perhaps elsewhere in the brain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870481

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  3 in total

1.  Concept and Management of Treatment Resistant Schizophrenia (TRS).

Authors:  Nitesh Painuly; Nitin Gupta; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2004-04       Impact factor: 1.759

Review 2.  Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.

Authors:  Seong S Shim; Michael D Hammonds; Baik S Kee
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

3.  Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.

Authors:  R Corbett; F Camacho; A T Woods; L L Kerman; R J Fishkin; K Brooks; R W Dunn
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.